摘要
抑郁症是常见的精神障碍性疾病,多呈慢性、复发性病程,对患者的社会功能有较大影响。大多数抑郁症患者可用药物和心理疗法治愈,但有20%～30%的病例对各种治疗没有反应,即通常所称的难治性抑郁症(TRD)。本文就近年针对TRD的药物治疗研究进展进行综述。
Depression is a common psychiatry disorder with chronic course and high relapse rate. Most patients with depression disorder can acquire full remission after adequate treatment with pharmacological and psychological therapies, but 20% to 30% respond poorly to treatment, which means treatment-resistant depression. This article reviewed the development of pharmacological treatments for treatment-resistant depression.
出处
《世界临床药物》
CAS
2009年第4期212-219,共8页
World Clinical Drug
关键词
难治性抑郁症
药物治疗
抗抑郁药
增效剂
treatment-resistant depression
pharmacological treatment
antidepressant
augmentation
